Pulse Biosciences Announces Preliminary Findings from its CellFX nsPFA 360 Cardiac Catheter First-In-Human Feasibility Study to be Featured in Podium Presentation at the AF Symposium
Stock Information for Pulse Biosciences Inc
Loading
Please wait while we load your information from QuoteMedia.